2022
DOI: 10.2139/ssrn.4287469
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of the Prognosis between Early-Onset and Later-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…While a recent metanalysis found that there was no material difference in cancer specific survival in EOCRC compared to older patients [7], strategies are needed to help improve outcomes in EOCRC. One issue affecting EOCRC internationally is delay to diagnosis [5,18], with delays contributing to more advanced stage at diagnosis, and resulting in poorer outcomes [19].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…While a recent metanalysis found that there was no material difference in cancer specific survival in EOCRC compared to older patients [7], strategies are needed to help improve outcomes in EOCRC. One issue affecting EOCRC internationally is delay to diagnosis [5,18], with delays contributing to more advanced stage at diagnosis, and resulting in poorer outcomes [19].…”
Section: Discussionmentioning
confidence: 99%
“…The clinical characteristics of EOCRC can differ from late-onset colorectal cancer (LOCRC, diagnosed over 50 years of age), with EOCRC more likely to be left sided (sigmoid and rectum), have higher rates of mucinous or signet ring histology, be poorly differentiated, and present with advanced (stage 3 or 4) disease [5,6]. Despite these differences, a recent meta-analysis found no overall difference in cancer specific survival between early-onset and late-onset disease [7].…”
Section: Introductionmentioning
confidence: 99%
“…CRD42022334697). 22 This systematic review and meta-analysis followed the 2020 Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 23 and Meta-analyses of Observational Studies in Epidemiology (MOOSE) reporting guidelines. 24…”
Section: Review Registration and Approachmentioning
confidence: 99%